Erythrocyte glutathione peroxidase activity, plasma malondialdehyde and erythrocyte glutathione levels in hemodialysis and CAPD patients

Ozden M. Ö. , Maral H. , Akaydin D., Cetinalp P., Kalender B.

CLINICAL BIOCHEMISTRY, vol.35, no.4, pp.269-273, 2002 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 35 Issue: 4
  • Publication Date: 2002
  • Doi Number: 10.1016/s0009-9120(02)00307-7
  • Title of Journal : CLINICAL BIOCHEMISTRY
  • Page Numbers: pp.269-273
  • Keywords: continuous ambulatory peritoneal dialysis, hemodialysis, glutathione, glutathione peroxidase, malondialdehyde, CHRONIC-RENAL-FAILURE, PERITONEAL-DIALYSIS PATIENTS, LIPID-PEROXIDATION, EXCRETION, URINE, ABNORMALITIES, FORMALDEHYDE, ACETALDEHYDE, CONSEQUENCE, MECHANISM


Objectives: Cardiovascular disease is the major cause of mortality in patients receiving hemodialysis (HD) and continuous ambulatory peritoneal dialysis (CAPD) due to chronic renal failure. Increased lipid peroxidation and depletion of antioxidants may contribute to increased risk of atherosclerosis. We have therefore assessed the effect of hemodialysis and CAPD on oxidant and antioxidant status.